We are monitoring the impact of COVID-19 & Recession alarm on MEA Cell Fractionation Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa Cell Fractionation Market Research Report – Segmented By Product, Type Of Cell, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2546
Pages: 140

MEA Cell Fractionation Market Size (2022 to 2027)

The Middle East and Africa Cell Fractionation Market size was valued at USD 0.35 Billion in 2022. It is estimated to be growing at a CAGR of 8.65% and worth USD 0.53 Billion by 2027.

Cell Fractionation is in high demand because of the growing number of cultured cell processes used in diagnostic and research applications. As a result, cell lysis/cell fractionation sector companies will see rapid growth in developing countries. The increased frequency of chronic diseases, scientific technology advancements, and supporting regulation for cell-based research in emerging nations are all contributing factors. In addition, the government's increased funding for research, the expansion of the biotechnology and biopharmaceutical sectors, the rise in illness prevalence, and a growing focus on customized therapy are a few of the driving factors for the Middle East and Africa cell fractionation market growth.

The market is further expected to grow due to increased government funding for research, burgeoning biotechnology and biopharmaceutical businesses, a high prevalence of disorders, and a growing emphasis on customized therapy. Researchers are using disruptive cells to study morphology and organization of organelles to develop new cell therapies and other cell-based treatments. Several government bodies have increased their financing to support cell-based research because of its importance. As a result, a slew of government entities has stepped up to give financial aid in the form of investments and funds. Furthermore, there is a significant increase in infectious diseases in the current condition, which is accelerating the market's growth rate.

High expenditure or expense of cell-based research are a few barriers to the cell fractionation market in this region, and providers of cell-based research or public services should spend a lot of money. A scarcity of skilled workers further constrains the Middle East and Africa market's growth rate. In the Cell Fractionation sector, a lack of experienced professionals is a major stumbling block. Furthermore, new entrant survival acts as a restraint in the Cell Fractionation market in the MEA region. COVID-19 has a significant impact on the cell fractionation market, particularly economics. COVID-19 has an economic influence on the cell fractionation market. Furthermore, the COVID-19 pandemic affects the manufacturing supply chain.

This research report has been segmented and sub-segmented the Middle East and Africa Cell Fractionation Market into the following categories.

By Product:

  • Consumables
  • Reagents
    • Enzymes
    • Detergent Solutions
  • Beads
  • Disposables
  • Instruments
    • Sonicator
    • Homogenizer

By Cell Type: 

  • Microbial
  • Mammalian

By End User: 

  • Research Laboratories
  • Biopharmaceuticals
  • Biotechnology Companies

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

In this discipline, the requirement for separating subcellular proteins from growing cells has been an enormous achievement. Furthermore, the growing need for pure cellular fractions has prompted the development of new technologies, which has boosted the cell fractionation market in this region. Due to the continuing expansion of the biotechnology sector, the Middle East and Africa Cell Fractionation market is expected to grow significantly over the projected period and continues to grow during the forecast period.

During the forecast period, the cell fractionation market in the Middle East and Africa is likely to be dominated by Saudi Arabia. This is due to increased government financing for R&D, a greater focus on customized medicine, and the growth of the biopharmaceutical and biotechnology sectors. In addition, improvements are also aiding the development of the market in this region in research infrastructure facilities.

UAE is predicted to have the highest share of the Middle East and Africa Cell Fractionation market, following Saudi Arabia. The industry is expected to be driven by biotech methods being adopted by medicine, agriculture, and bio services companies. Furthermore, an increase in investments in R&D linked to biotechnological processes by various government and corporate companies, as well as academia, is predicted to propel the market considerably.


Companies playing a promising role in the MEA cell fractionation market profiled in the report are Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., F. Hoffman-La Roche AG, Merck KGaA, Miltenyi Biotec, QIAGEN N., Qsonica and Thermo Fisher Scientific Inc.


                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 Product                                                        

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Reagents                                 


                                       Detergent Solutions                        

                                5.1.4 Beads                                        

                                5.1.5 Disposables                                            

                                5.1.6 Instruments                                           



                                5.1.7  Y-o-Y Growth Analysis, By Product                                              

                                5.1.8  Market Attractiveness Analysis, By Product                                            

                                5.1.9  Market Share Analysis, By Product                                              

                5.2 Type of cell                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Microbial                                  

                                5.2.3 Mammalian                                            

                                5.2.4 Y-o-Y Growth Analysis, By Type of cell                                        

                                5.2.5 Market Attractiveness Analysis, By Type of cell                                      

                                5.2.6 Market Share Analysis, By Type of cell                                        

                5.3 End Users                                                    

                                5.3.1 Introduction                                           

                                5.3.2 Research Laboratories and Institutes                                          

                                5.3.3 Biopharmaceutical Companies                                       

                                5.3.4  iotechnology Companies                                 

                                5.3.5 Y-o-Y Growth Analysis, By End Users                                           

                                5.3.6  Market Attractiveness Analysis, By End Users                                        

                                5.3.7 Market Share Analysis, By End Users                                           

  1. Geographical Analysis

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Geographical Area                     

                                       By Product                           

                                       By Type of cell                    

                                       By End Users                      

                                6.1.4  Market Attractiveness Analysis                                     

                                       By Geographical Area                     

                                       By Product                           

                                       By Type of cell                    

                                       By End Users                      

                                6.1.5  Market Share Analysis                                      

                                       By Geographical Area                     

                                       By Product                           

                                       By Type of cell                    

                                       By End Users                      

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Beckman Coulter                                                     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Becton                                                          

                8.3 Dickinson and Company                                                        

                8.4 Bio-Rad Laboratories                                                              

                8.5 Cell Signaling Technology                                                      

                8.6 Miltenyi Biotec                                                          

                8.7 Thermo Fisher Scientific Inc.                                               

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          


  1. a) List of Tables
  2. b) List of Figures


  1. The Middle East & Africa Cell Fractionation Market, By Product, From 2022 - 2027 (USD Billion)
  2. The Middle East & Africa Consumables Market, By Region, From 2022 - 2027 (USD Billion)
  3. The Middle East & Africa Instruments Market, By Region, From 2022 - 2027 (USD Billion)
  4. The Middle East & Africa Cell Fractionation Market, By Type of Cell, From 2022 - 2027 (USD Billion)
  5. The Middle East & Africa Microbial Market, By Region, From 2022 - 2027 (USD Billion)
  6. The Middle East & Africa Mamalian Market, By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa Cell Fractionation Market, By End Users, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Research Laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Biopharmaceutical companies Market, By Region, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Billion)
  11. Middle East Cell Fractionation Market, By Product, From 2022 - 2027 (USD Billion)
  12. Middle East Cell Fractionation Market, By Type of Cell, From 2022 - 2027 (USD Billion)
  13. Middle East Cell Fractionation Market, By End Users, From 2022 - 2027 (USD Billion)
  14. Africa Cell Fractionation Market, By Product, From 2022 - 2027 (USD Billion)
  15. Africa Cell Fractionation Market, By Type of Cell, From 2022 - 2027 (USD Billion)
  16. Africa Cell Fractionation Market, By End Users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample